Fortunato Morabito

11.9k total citations
294 papers, 5.0k citations indexed

About

Fortunato Morabito is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Fortunato Morabito has authored 294 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Genetics, 136 papers in Hematology and 103 papers in Oncology. Recurrent topics in Fortunato Morabito's work include Chronic Lymphocytic Leukemia Research (121 papers), Lymphoma Diagnosis and Treatment (85 papers) and Multiple Myeloma Research and Treatments (77 papers). Fortunato Morabito is often cited by papers focused on Chronic Lymphocytic Leukemia Research (121 papers), Lymphoma Diagnosis and Treatment (85 papers) and Multiple Myeloma Research and Treatments (77 papers). Fortunato Morabito collaborates with scholars based in Italy, United States and Spain. Fortunato Morabito's co-authors include Massimo Gentile, Vincenzo Callea, Antonino Neri, Caterina Stelitano, Manlio Ferrarini, Massimo Martino, Pasquale Iacopino, Giovanna Cutrona, Ernesto Vigna and Stefano Molica and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fortunato Morabito

278 papers receiving 4.9k citations

Peers

Fortunato Morabito

HEMAT

GENET

ONCOL

PFM

Didier Bouscary France

Itaru Matsumura Japan

Giovanni D’Arena Italy

Steven H. Bernstein United States

Stanley R. Frankel United States

Wei Xu China

Rishu Takimoto Japan

Kylie D. Mason Australia

Paresh Vyas United Kingdom

Felicetto Ferrara Italy

Didier Bouscary France

Fortunato Morabito

3.5k ×1.7

2.3k ×1.1

HEMAT

1.1k ×0.6

GENET

1.4k ×0.9

ONCOL

821 ×0.6

PFM

Citations per year, relative to Fortunato Morabito Fortunato Morabito (= 1×) peers Didier Bouscary

Countries citing papers authored by Fortunato Morabito

Since Specialization

Citations

This map shows the geographic impact of Fortunato Morabito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fortunato Morabito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fortunato Morabito more than expected).

Fields of papers citing papers by Fortunato Morabito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fortunato Morabito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fortunato Morabito. The network helps show where Fortunato Morabito may publish in the future.

Co-authorship network of co-authors of Fortunato Morabito

This figure shows the co-authorship network connecting the top 25 collaborators of Fortunato Morabito. A scholar is included among the top collaborators of Fortunato Morabito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fortunato Morabito. Fortunato Morabito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bruzzese, Antonella, Ernesto Vigna, Enrica Antonia Martino, et al.. (2025). TP53 ‐Mutated Acute Myeloid Leukemia: Unanswered Questions. Hematological Oncology. 43(4). e70106–e70106.

Mangone, Lucìa, Valentina Mastrofilippo, Fortunato Morabito, et al.. (2025). Impact of COVID-19 on the Stage and Treatment of Endometrial Cancer: A Cancer Registry Analysis from an Italian Comprehensive Cancer Center. Cancers. 17(16). 2686–2686.

Morabito, Fortunato, et al.. (2024). MULTIDISCIPLINARY APPROACH IN ONCOLOGY: ENHANCING PATIENT OUTCOMES THROUGH COLLABORATIVE CARE. 4(2). 84–84.

Mangone, Lucìa, et al.. (2024). A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications. International Journal of Environmental Research and Public Health. 21(10). 1333–1333.

Mangone, Lucìa, Maurizio Zizzo, Maria Banzi, et al.. (2024). Impact of Multidisciplinary Team Management on Survival and Recurrence in Stage I–III Colorectal Cancer: A Population-Based Study in Northern Italy. Biology. 13(11). 928–928. 4 indexed citations

Mangone, Lucìa, Fortunato Morabito, Giovanni Tripepi, et al.. (2024). Survival Risk Score for Invasive Nonmetastatic Breast Cancer: A Real-World Analysis. JCO Global Oncology. 10(10). e2300390–e2300390.

Mangone, Lucìa, Maria Banzi, Angela Damato, et al.. (2024). Characteristics and Outcomes of Colorectal Cancer Patients Cared for by the Multidisciplinary Team in the Reggio Emilia Province, Italy. Cancers. 16(13). 2390–2390. 3 indexed citations

Bruzzese, Antonella, Enrica Antonia Martino, Francesco Mendicino, et al.. (2024). Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications. European Journal Of Haematology. 112(6). 860–869.

Bruzzese, Antonella, Ernesto Vigna, Enrica Antonia Martino, et al.. (2023). Myelodysplastic syndromes with ring sideroblasts. Hematological Oncology. 41(4). 612–620. 1 indexed citations

10.

Mangone, Lucìa, Valentina Mastrofilippo, Annamaria Pezzarossi, et al.. (2023). Optimizing Outcomes through a Multidisciplinary Team Approach in Endometrial Cancer. Healthcare. 12(1). 64–64. 5 indexed citations

11.

Bruzzese, Antonella, Enrica Antonia Martino, Francesco Mendicino, et al.. (2023). Tagraxofusp in myeloid malignancies. Hematological Oncology. 42(1). e3234–e3234. 2 indexed citations

12.

Menichini, Paola, Paola Monti, Giovanna Cutrona, et al.. (2021). Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?. Cells. 10(1). 98–98. 32 indexed citations

13.

Morabito, Fortunato, Giovanni Tripepi, Enrica Antonia Martino, et al.. (2021). Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma. Drug Design Development and Therapy. Volume 15. 2969–2978. 12 indexed citations

14.

Ronchetti, Domenica, Paola Monti, Giovanna Cutrona, et al.. (2020). NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome. Non-Coding RNA. 6(1). 11–11. 10 indexed citations

15.

Morabito, Fortunato, Anna Grazia Recchia, Ernesto Vigna, et al.. (2019). An in-depth evaluation of acalabrutinib for the treatment of mantle-cell lymphoma. Expert Opinion on Pharmacotherapy. 21(1). 29–38. 3 indexed citations

16.

Delgado, Julio, Michael Doubek, Tycho Baumann, et al.. (2017). Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers ( IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL‐IPI. American Journal of Hematology. 92(4). 375–380. 66 indexed citations

17.

Martino, Massimo, Maurizio Postorino, Giuseppe Messina, et al.. (2013). Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs. Clinical Lymphoma Myeloma & Leukemia. 14(2). 148–154. 12 indexed citations

18.

Mosca, Laura, Sonia Fabris, Marta Lionetti, et al.. (2010). Integrative Genomics Analyses Reveal Molecularly Distinct Subgroups of B-Cell Chronic Lymphocytic Leukemia Patients with 13q14 Deletion. Clinical Cancer Research. 16(23). 5641–5653. 38 indexed citations

19.

Ria, Roberto, Katia Todoerti, Simona Berardi, et al.. (2009). Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma. Clinical Cancer Research. 15(17). 5369–5378. 75 indexed citations

20.

Palumbo, Antonio, Maria Teresa Ambrosini, Giulia Benevolo, et al.. (2006). Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma. Blood. 109(7). 2767–2772. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact